Notice of Effectiveness (effect)
07 Giugno 2023 - 12:03PM
Edgar (US Regulatory)
|
UNITED STATES
|
|---|
|
SECURITIES AND EXCHANGE COMMISSION
|
|---|
|
Washington, D.C. 20549
|
|---|
NOTICE OF EFFECTIVENESS |
|---|
|
| Effective Date: | June 06,
2023 |
|---|
| Accession Number: | 0001104659-23-066683 |
|---|
| Submission Type: | POS AM |
|---|
| CIK: | 0001541157 |
|---|
| Company Name: | Akari Therapeutics Plc |
|---|
| File Number: | 333-233048 |
|---|
Grafico Azioni Akari Therapeutics (NASDAQ:AKTX)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Akari Therapeutics (NASDAQ:AKTX)
Storico
Da Feb 2024 a Feb 2025
